Texas bills · 89th Legislature (2025)
Texas HB 3785
Relating to labeling requirements for compounded drug products.
- Introduced
- In committee
- Passed House
- Passed Senate
- To Governor
- Became law
Sponsors
- Gervin-Hawkins (Democratic)
Summary
No official summary is available for this bill.
Latest action(Apr 28, 2025): Failed to receive affirmative vote in comm.
Text versions
Roll-call votes
No recorded votes on this bill.
Actions
- Apr 28, 2025 · House
Failed to receive affirmative vote in comm. - Apr 28, 2025 · House
Committee substitute considered in committee - Apr 28, 2025 · House
Considered in public hearing - Apr 14, 2025 · House
Left pending in committee - Apr 14, 2025 · House
Testimony taken/registration(s) recorded in committee - Apr 14, 2025 · House
Considered in public hearing - Mar 26, 2025 · House
Referred to Public Health - Mar 26, 2025 · House
Read first time - Mar 5, 2025 · House
Filed